New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.

Bioorg Med Chem

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, C/Irunlarrea s/n, 31008 Pamplona, Spain.

Published: April 2010

Mycobacterium tuberculosis (M.Tb) is a bacillus capable of causing a chronic and fatal condition in humans known as tuberculosis (TB). It is estimated that there are 8 million new cases of TB per year and 3.1 million infected people die annually. Thirty-six new amide quinoxaline 1,4-di-N-oxide derivatives have been synthesized and evaluated as potential anti-tubercular agents, obtaining biological values similar to the reference compound, Rifampin (RIF).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2010.02.024DOI Listing

Publication Analysis

Top Keywords

14-di-n-oxide derivatives
8
3-methylquinoxaline-2-carboxamide 14-di-n-oxide
4
derivatives anti-mycobacterium
4
anti-mycobacterium tuberculosis
4
tuberculosis agents
4
agents mycobacterium
4
mycobacterium tuberculosis
4
tuberculosis mtb
4
mtb bacillus
4
bacillus capable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!